# Varex Imaging Corporation (VREX) Investor Outlook: A Promising Upside of 47% Awaits

- Link: https://www.directorstalkinterviews.com/varex-imaging-corporation-vrex-investor-outlook-a-promising-upside-of-47-awaits/4121230044
- Published: 2025-12-11T11:38:11+00:00
- Author: Madison Wilson

Varex Imaging Corporation (NASDAQ: VREX), a prominent player in the healthcare sector
specializing in medical devices, is capturing investor attention with its substantial
potential upside of 47.01%. With a market capitalization of $487.77 million, this
Salt Lake City-based company is carving out a significant niche in both medical 
and industrial X-ray imaging components.

Varex Imaging’s current stock price stands at $11.70, with a recent modest increase
of 0.18, or 0.02%. Over the past 52 weeks, the stock has fluctuated between $6.88
and $15.52, indicating a robust volatility that could intrigue investors looking
for both growth and risk management opportunities. Notably, the stock’s 50-day and
200-day moving averages are $11.64 and $10.12, respectively, signaling a steady 
upward trend that might appeal to technical analysts.

Despite not having established a trailing P/E ratio due to a current net income 
deficit, the forward P/E of 12.16 suggests potential earnings growth that could 
align with investor expectations. The company reported a revenue growth of 11.30%,
which highlights its ability to expand even in challenging market conditions. However,
the negative EPS of -1.70 and a return on equity of -13.58% might raise concerns
about profitability and efficiency, urging investors to weigh these factors carefully.

Varex Imaging’s free cash flow of $39.53 million is a positive indicator of its 
ability to fund operations and potentially invest in further growth. Although the
company does not currently offer dividends, the zero payout ratio means all profits
are reinvested into the business, potentially enhancing future earnings.

Analyst sentiment towards Varex Imaging is predominantly positive, with four buy
ratings and only one hold, and no sell ratings. The target price range is set between
$12.00 and $22.00, with an average target of $17.20, supporting the substantial 
upside potential. This optimistic outlook from analysts underscores an attractive
entry point for those considering long-term investment in the healthcare technology
space.

From a technical standpoint, the relative strength index (RSI) of 34.47 suggests
that the stock is approaching oversold territory, which could present a buying opportunity
for value-seeking investors. The MACD and signal line values at -0.03 and -0.08,
respectively, might indicate a potential for upward momentum in the near term.

Varex Imaging operates through two segments: Medical and Industrial. The Medical
division focuses on an array of X-ray imaging components used in critical healthcare
applications such as CT scans, mammography, and oncology, among others. Concurrently,
the Industrial segment delivers solutions for security and inspection applications,
such as baggage screening and non-destructive testing. This diversification enables
Varex to capitalize on a broad spectrum of market needs across various geographical
regions, including North America, Europe, and Asia.

Incorporated in 2016, Varex Imaging continues to make strides in innovation and 
market expansion, driven by a commitment to enhancing imaging quality and operational
efficiency for its customers. While there are challenges to tackle, such as achieving
positive net income and improving return on equity, the company’s strategic initiatives
and the healthcare sector’s enduring demand provide a solid foundation for future
growth.

For investors, Varex Imaging presents a compelling case of high risk and high reward,
with significant potential for appreciation. As the healthcare industry evolves,
Varex’s technological advancements and market penetration could lead to substantial
returns for those willing to invest in its promising trajectory.

Share on:
